Zusammenfassung
Eine Kritik der Methoden, die zur Bestimmung der Aktivität der renalen Pressorfunktion während Hypertension oder Natriumgleichgewicht benutzt wurden, ergibt eine gute Übereinstimmung der Ergebnisse. Es scheint eine umgekehrte Beziehung zwischen den Mengen der renalen pressorischen Substanzen in den Nieren und dem Auftreten der Nephrosklerose zu bestehen. Für die Beteiligung des Renins an der Pathogenese der benignen, renal und hormonell bedingten Hypertension besteht kein Anhaltspunkt.
Literatur
C. C. J. Carpenter, J. O. Davis, andC. R. Ayers, J. clin. Invest.40, 2026 (1961).
P. M. Hartroft andW. S. Hartroft, J. exp. Med.97, 415 (1953).
F. W. Dunihue,Factors Regulating Blood Pressure (Josiah Macy, Jr., Foundation, New York 1948), p. 11.
R. Edelman andP. M. Hartroft, Circulation Res.9, 1069 (1961).
F. Gross andP. Lichtlen, Proc. Soc. exp. Biol. Med.98, 341 (1958).
F. Gross andF. Sulser, Arch. exp. Path. Pharmak.229, 338 (1956).
T. Omae, G. M. C. Masson, andI. H. Page, Amer. J. Physiol.199, 637 (1960).
T. Omae, G. M. C. Masson, andI. H. Page, Circulation Res.9, 441 (1961).
P. Blaquier, D. Bohr, andS. W. Hoobler, Amer. J. Physiol.198, 1148 (1960).
J. L. Prado, Z. P. Picarelli, R. Kupper, E. S. Prado, andJ. R. Valle, Circulation Res.2, 359 (1954).
E. Braun-Menendez, M. R. Covian, andC. E. Rapela, Rev. Soc. Argent. Biol.23, 131 (1947).
P. M. Hartroft, J. exp. Med.105, 501 (1957).
B. S. Garber, F. W. McCoy, E. R. Hayes, andB. H. Marks, Arch. int. Pharmacodyn.121, 275 (1959).
L. Tobian, J. Thompson, R. Twedt, andJ. Janacek, J. clin. Invest.37, 660 (1958).
L. Tobian, A. Tomboulian, andJ. Janecek, J. clin. Invest.38, 605 (1959).
A. Mikasa andG. M. C. Masson, Proc. Soc. exp. Biol. Med.106, 315 (1961).
J. U. Schlegel andS. Okamoto, J. Urology86, 27 (1961).
K. G. Kohlstaedt andI. H. Page, J. exp. Med.72, 201 (1940).
F. Gross andF. Sulser, Arch. exp. Path. Pharmak.229, 374 (1956).
G. M. C. Masson, A. Mikasa, andH. Yasuda, Circulation (Abstract)24, 990 (1961).
B. H. Marks, B. G. Garber, andF. W. McCoy, Proc. Soc. exp. Biol. Med.105, 593 (1960).
P. M. Hartroft andR. Edelman,Edema (W. B. Saunders Co., Philadelphia 1960), p. 63.
N. Goormagtigh,La fonction endocrine des artérioles rénales; son rôle dans la pathologie de l'hypertension arterielle (Fonteyn, Louvain 1944).
Ch. Oberling andP. Y. Hatt, Ann. Anat. Path.5/4, 441 (1960).
R. Hess andA. G. E. Pearse, Brit. J. exp. Path.60, 243 (1959).
R. Hess andF. Gross, Amer. J. Physiol.197, 869 (1959).
L. Tobian, J. Janecek, andA. Tomboulian, Proc. Soc. exp. Biol. Med.100, 94 (1959).
L. Tobian, Physiol. Rev.40, 280 (1960).
F. Gross, Klin. Wschr.36, 693 (1958).
I. H. Page andF. M. Bumpus, Physiol. Rev.41, 331 (1961).
M. A. Floyer,Hypertension (Ciba Foundation Symposium, Little, Brown, and Co., Boston 1954), p. 155.
P. Milliez, Rev. Franc. Études clin. biol.6, 641 (1961).
I. H. Page,The Medical Clinics of North America (W. B. Saunders Co., Philadelphia 1961), vol. 45, p. 235.
G. M. C. Masson, J. B. Hazard, A. C. Corcoran, andI. H. Page, Arch. Path.49, 641 (1950).
P. M. Hartroft, L. N. Newmark, andJ. A. Pitcock,Hypertension (First Hahnemann Symposium on Hypertensive Disease, W. B. Saunders Co., Philadelphia 1959), p. 24.
H. W. Deane andG. M. C. Masson, J. clin. Endocrinol.11, 193 (1951).
G. M. C. Masson, A. C. Corcoran, andI. H. Page,C. R. Congrès de Cardiologie (J. B. Baillère et fils, Paris 1950), tome III.
A. B. Eisenstein andP. M. Hartroft, Endocrinology60, 634 (1957).
P. M. Hartroft andA.B. Eisenstein, Endocrinology60, 641 (1957).
L. Tobian, Ann. int. Med.52, 395 (1960).
P. Biron, E. Koiw, W. Nowaczynski, J. Brouillet, andJ. Genest, J. clin. Invest40, 338 (1961).
J. H. Laragh, S. Ulick, V. Januszewicz, Q. B. Deming, W. B. Kelly, andS. Lieberman, J. clin. Invest.39, 1091 (1960).
G. M. C. Masson, A. C. Corcoran, andI. H. Page, Amer. med. Assoc. Arch. Path.53, 217 (1952).
G. M. C. Masson, A. C. Corcoran, andI. H. Page, Proc. Soc. exp. Biol. Med.84, 284 (1953).
F. Sulser andF. Gross, Helv. physiol. Acta14, C45 (1956).
H. Selye andH. Stone, J. Urology56, 399 (1946).
D. Loomis, Arch. Path.41, 231 (1946).
F. Gross, P. Loustalot, andR. Meier, Acta endocrinol.26, 417 (1957).
F. Gross, P. Loustalot, andF. Sulser, Arch. exp. Path. Pharmak.229, 381 (1956).
F. Gross andP. Lichtlen, Amer. J. Physiol.195, 543 (1958).
H. Selye andC. E. Hall, Amer. Heart J.27, 338 (1944).
H. Sokabe, A. Mikasa, andG. M. C. Masson, unpublished observations.
G. M. C. Masson, A. C. Corcoran, H. P. Dustan, andI. H. Page, Amer. J. med. Sci.224, 175 (1952).
S. M. Friedman, C. L. Friedman, andM. Nakashima, Endocrinol.53, 633 (1953).
T. Omae andG. M. C. Masson, Endocrinol.66, 428 (1960).
F. Gross andH. Schmidt, Arch. exp. Path. Pharmak.233, 311 (1958).
S. M. Friedman, C. L. Friedman, andM. Nakashima, J. exp. Med.93, 361 (1951).
F. R. Skelton, Amer. J. Path.32, 1037 (1956).
M. L. Wiedman, F. W. Dunihue, andW. Van B. Robertson, J. Endocrinol.17, 261 (1958).
F. Gross andF. Sulser, Arch. exp. Path. Pharmak.230, 274 (1957).
J. A. Pitcock, P. M. Hartroft, andL. N. Newmark, Proc. Soc. exp. Biol. Med.100, 868 (1959).
C. Toussaint, R. Wolter, andP. Sibille, Rev. Belge Path.23, 83 (1953).
Author information
Authors and Affiliations
Additional information
Whenever used, the term renin has the same meaning as renal pressor substances and refers to a biological activity, not to a definite chemical entity.
Rights and permissions
About this article
Cite this article
Masson, G.M.C. Juxtaglomerular cells, renal pressor substances and nephrosclerosis. Experientia 18, 243–247 (1962). https://doi.org/10.1007/BF02148325
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02148325